Gabelli, Gamco continue to increase stake in Biosite

By Lisa Kerner

Charlotte, N.C., May 23 - Biosite Inc. shareholders led by Gamco Asset Management Inc. and Gabelli Funds, LLC purchased 106,700 shares of the company's stock on May 21 and May 22, priced from $91.76 to $91.83.

The investors beneficially own 1,683,034 shares, or 9.85%, of the San Diego-based biomedical company's outstanding stock, according to a schedule 13D filed with the Securities and Exchange Commission.

On May 16, the investors reported a 7.69% stake in Biosite.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.